january NUMBER december NUMBER NUMBER patients pathological stage ia iia hodgkins disease hd submitted mantle irradiation stage NUMBER NUMBER stage ii NUMBER patients submitted staging laparotomy cases large mediastinal mass excluded series delivered doses NUMBER gy involved areas NUMBER gy mediastinum NUMBER gy uninvolved sites patients stage NUMBER NUMBER stage ii NUMBER obtained complete remission actuarial overall os rates NUMBER NUMBER respectively efs rfs survival rates NUMBER NUMBER yr NUMBER NUMBER respectively occurrence disease relapse resulted statistical significant prognostic factor os univariate multivariate analysis distant extranodal recurrences significantly p001 related reduced os multivariate analysis stage determinant factor increased rfs extended field rt proved effective curative modality stage hd patients NUMBER NUMBER patients stage ii relapsed requiring salvage therapy analysis survival morbidity rates improve knowledge assist physicians choose therapeutic option offer hd patients NUMBER NUMBER yr event free relapse free long term treatment related